• FDA approves Emgality for migraine prevention

    7 monthes ago - By Healio

    The FDA recently approved Emgality, a once-monthly, self-administered, subcutaneous injection, for the preventive treatment of migraine in adults, according to a press release issued by the manufacturer.
    “Despite the devastating impact of migraine, only about 10% of people living with the disease are currently taking a preventive treatment,” Christi Shaw, president of Lilly Bio-Medicines, said in the release. “For more than 2 decades, Lilly has recognized this unmet need, and we have worked tirelessly to develop a new option specifically designed for the prevention of
    Read more ...


  • FDA Greenlights Galcanezumab for Migraine Prevention

    7 monthes ago - By Medscape

    On the heels of recent approvals for two other calcitonin gene-related peptide antagonists for the prevention of migraine in adults, the FDA has approved the anti-CGRP galcanezumab.
    FDA Approvals
    Read more ...